- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Table of Contents
Case Reports in Medicine
Volume 2012 (2012), Article ID 607104, 5 pages
Transient Monoclonal Gammopathy Induced by Disseminated Staphylococcus aureus Infection
1st Department of Internal Medicine, “Georgios Papanikolaou” General Hospital, Exochi, 570 10 Thessaloniki, Greece
Received 25 September 2012; Accepted 20 November 2012
Academic Editor: Christos D. Lionis
Copyright © 2012 Dimitrios Stoimenis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. A. Kyle, T. M. Therneau, S. Vincent Rajkumar et al., “A long-term study of prognosis in monoclonal gammopathy of undetermined significance,” New England Journal of Medicine, vol. 346, no. 8, pp. 564–569, 2002.
- S. L. Strobel, “Transient paraproteinemia: an intriguing immunological anomaly,” Annals of Clinical and Laboratory Science, vol. 33, no. 3, pp. 265–270, 2003.
- R. A. Kyle and S. Vincent Rajkumar, “Monoclonal gammopathy of undetermined significance,” British Journal of Haematology, vol. 134, no. 6, pp. 573–589, 2006.
- R. K. Wadhera and S. V. Rajkumar, “Prevalence of monoclonal gammopathy of undetermined significance: a systematic review,” Mayo Clinic Proceedings, vol. 85, no. 10, pp. 933–942, 2010.
- G. J. Ligthart, J. Radl, J. X. Corberand et al., “Monoclonal gammopathies in human aging: increased occurrence with health status,” Mechanisms of Ageing and Development, vol. 52, no. 2-3, pp. 235–243, 1990.
- J. P. Bida, R. A. Kyle, T. M. Therneau et al., “Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients,” Mayo Clinic Proceedings, vol. 84, no. 8, pp. 685–693, 2009.
- H. Vodopick, S. J. Chaskes, A. Solomon, and J. A. Stewart, “Transient monoclonal gammopathy associated with cytomegalovirus infection,” Blood, vol. 44, no. 2, pp. 189–195, 1974.
- P. Sève, R. Turner, K. Stankovic, L. Perard, and C. Broussolle, “Transient monoclonal gammopathy in a patient with Bartonella quintana endocarditis,” American Journal of Hematology, vol. 81, no. 2, pp. 115–117, 2006.
- G. Valopoulos, P. Sideris, K. Anargyrou, R. Melas, N. Piessas, and K. Konstantopoulos, “Transient monoclonal hypergammaglobulinemia during the course of a Rickettsia infection,” Infection, vol. 30, no. 4, pp. 249–250, 2002.
- S. Borges, A. Costa, F. Bourbon, and F. Reis, “Brucella endocarditis,” Medicina Interna, vol. 16, pp. 81–85, 2009.
- N. Mohandasa, M. Singha, R. B. S. Singha, and J. Damodharana, “Monoclonal gammopathy in HIV and hepatitis B co-infection: a case report,” Sri Ramachandra Journal of Medicine, vol. 3, pp. 29–31, 2010.
- S. Jagannath, P. Richardson, and N. C Munshi, “Multiple myeloma and other plasma cell dyscrasias,” Cancer Management, 13th edition, http://www.cancernetwork.com/cancer-management/myeloma/article/10165/1802756.
- R. Ning, X. Zhang, X. Guo, and Q. Li, “Staphylococcus aureus regulates secretion of interleukin-6 and monocyte chemoattractant protein-1 through activation of nuclear factor kappab signaling pathway in human osteoblasts,” Brazilian Journal of Infectious Diseases, vol. 15, no. 3, pp. 189–194, 2011.
- W. C. Cheung and B. Van Ness, “Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells,” Leukemia, vol. 16, no. 6, pp. 1182–1188, 2002.